BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 19864077)

  • 1. Quality of life after stereotactic radiotherapy for stage I non-small-cell lung cancer.
    van der Voort van Zyp NC; Prévost JB; van der Holt B; Braat C; van Klaveren RJ; Pattynama PM; Levendag PC; Nuyttens JJ
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):31-7. PubMed ID: 19864077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival and quality of life after stereotactic or 3D-conformal radiotherapy for inoperable early-stage lung cancer.
    Widder J; Postmus D; Ubbels JF; Wiegman EM; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e291-7. PubMed ID: 21640503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life and survival in the 2 years after surgery for non small-cell lung cancer.
    Kenny PM; King MT; Viney RC; Boyer MJ; Pollicino CA; McLean JM; Fulham MJ; McCaughan BC
    J Clin Oncol; 2008 Jan; 26(2):233-41. PubMed ID: 18086802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life during 5 years after stereotactic radiotherapy in stage I non-small cell lung cancer.
    Ubels RJ; Mokhles S; Andrinopoulou ER; Braat C; van der Voort van Zyp NC; Aluwini S; Aerts JG; Nuyttens JJ
    Radiat Oncol; 2015 Apr; 10():98. PubMed ID: 25896787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial.
    Sundstrøm S; Bremnes R; Aasebø U; Aamdal S; Hatlevoll R; Brunsvig P; Johannessen DC; Klepp O; Fayers PM; Kaasa S
    J Clin Oncol; 2004 Mar; 22(5):801-10. PubMed ID: 14990635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating quality of life and pulmonary function of long-term survivors of non-small cell lung cancer treated with radical or postoperative radiotherapy.
    Ozturk A; Sarihan S; Ercan I; Karadag M
    Am J Clin Oncol; 2009 Feb; 32(1):65-72. PubMed ID: 19194128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic radiotherapy with real-time tumor tracking for non-small cell lung cancer: clinical outcome.
    van der Voort van Zyp NC; Prévost JB; Hoogeman MS; Praag J; van der Holt B; Levendag PC; van Klaveren RJ; Pattynama P; Nuyttens JJ
    Radiother Oncol; 2009 Jun; 91(3):296-300. PubMed ID: 19297048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC).
    Zimmermann FB; Geinitz H; Schill S; Thamm R; Nieder C; Schratzenstaller U; Molls M
    Acta Oncol; 2006; 45(7):796-801. PubMed ID: 16982542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC).
    Hof H; Muenter M; Oetzel D; Hoess A; Debus J; Herfarth K
    Cancer; 2007 Jul; 110(1):148-55. PubMed ID: 17516437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer.
    Xia T; Li H; Sun Q; Wang Y; Fan N; Yu Y; Li P; Chang JY
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):117-25. PubMed ID: 16765528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy.
    Baumann P; Nyman J; Hoyer M; Wennberg B; Gagliardi G; Lax I; Drugge N; Ekberg L; Friesland S; Johansson KA; Lund JA; Morhed E; Nilsson K; Levin N; Paludan M; Sederholm C; Traberg A; Wittgren L; Lewensohn R
    J Clin Oncol; 2009 Jul; 27(20):3290-6. PubMed ID: 19414667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients.
    Wulf J; Haedinger U; Oppitz U; Thiele W; Mueller G; Flentje M
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):186-96. PubMed ID: 15337555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries.
    Baumann P; Nyman J; Lax I; Friesland S; Hoyer M; Rehn Ericsson S; Johansson KA; Ekberg L; Morhed E; Paludan M; Wittgren L; Blomgren H; Lewensohn R
    Acta Oncol; 2006; 45(7):787-95. PubMed ID: 16982541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung stereotactic body radiation therapy (SBRT) delivered over 4 or 11 days: a comparison of acute toxicity and quality of life.
    Jain S; Poon I; Soliman H; Keller B; Kim A; Lochray F; Yeung L; Cheung P
    Radiother Oncol; 2013 Aug; 108(2):320-5. PubMed ID: 23993401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Size matters: a comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT).
    Dunlap NE; Larner JM; Read PW; Kozower BD; Lau CL; Sheng K; Jones DR
    J Thorac Cardiovasc Surg; 2010 Sep; 140(3):583-9. PubMed ID: 20478576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic body radiation therapy (SBRT) for early-stage lung cancer.
    Hiraoka M; Matsuo Y; Nagata Y
    Cancer Radiother; 2007; 11(1-2):32-5. PubMed ID: 17158081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes of stereotactic radiotherapy for stage I non-small cell lung cancer using a novel irradiation technique: patient self-controlled breath-hold and beam switching using a combination of linear accelerator and CT scanner.
    Onishi H; Kuriyama K; Komiyama T; Tanaka S; Sano N; Marino K; Ikenaga S; Araki T; Uematsu M
    Lung Cancer; 2004 Jul; 45(1):45-55. PubMed ID: 15196734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic body radiotherapy versus surgery for medically operable Stage I non-small-cell lung cancer: a Markov model-based decision analysis.
    Louie AV; Rodrigues G; Hannouf M; Zaric GS; Palma DA; Cao JQ; Yaremko BP; Malthaner R; Mocanu JD
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):964-73. PubMed ID: 20932688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of robotic stereotactic radiotherapy to peripheral stage I non-small cell lung cancer with curative intent.
    Brown WT; Wu X; Fayad F; Fowler JF; García S; Monterroso MI; de la Zerda A; Schwade JG
    Clin Oncol (R Coll Radiol); 2009 Oct; 21(8):623-31. PubMed ID: 19682875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic, high single-dose irradiation of stage I non-small cell lung cancer (NSCLC) using four-dimensional CT scans for treatment planning.
    Fritz P; Kraus HJ; Blaschke T; Mühlnickel W; Strauch K; Engel-Riedel W; Chemaissani A; Stoelben E
    Lung Cancer; 2008 May; 60(2):193-9. PubMed ID: 18045732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.